Clinical outcomes of switching to dolutegravir/lamivudine dual therapy in people living with HIV: A single‐centre retrospective study

Documenti analoghi

• Therapeutic drug monitoring of dolutegravir in children and adolescents living with HIV: A retrospective study
  di: E. Pilote, et al.
  Pubblicazione: (2025)
• Therapeutic drug monitoring of antimicrobials in a paediatric setting: A retrospective single‐centre study
  di: Gianluca Gazzaniga, et al.
  Pubblicazione: (2026)
• A preliminary analysis of the impact of pharmacogenetic variation on bictegravir and dolutegravir concentrations in individuals with HIV and tuberculosis
  di: A. Naidoo, et al.
  Pubblicazione: (2025)
• A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease
  di: Louise Rabbitt, et al.
  Pubblicazione: (2025)
• Association between anticholinergic burden and sleep quality in people living with HIV
  di: Maria Mazzitelli, et al.
  Pubblicazione: (2025)